A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study)
2015 ◽
Vol 45
(5)
◽
pp. 494-498
◽
2016 ◽
Vol 46
(2)
◽
pp. 174-177
◽
2018 ◽
Vol 48
(4)
◽
pp. 392-395
◽
2017 ◽
Vol 47
(7)
◽
pp. 664-667
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 4046-4046
◽
Keyword(s):
2008 ◽
Vol 38
(1)
◽
pp. 74-77
◽
2017 ◽
Vol 47
(10)
◽
pp. 986-990
◽
Keyword(s):
2019 ◽
Vol 49
(4)
◽
pp. 379-382
◽
Keyword(s):